Fisher & Paykel expects sharply lower half-year profit

Fisher & Paykel expects sharply lower half-year profit
The covid-19 boost is fading but F&P says it's in a good position. (Image: F&P Healthcare)
Rebecca Howard
Fisher & Paykel Healthcare shares fell as much as 9.6% after it said it expects first-half revenue to drop 26% and net profit to more than halve as covid-19 related sales continue to fade.The healthcare products manufacturer expects operating revenue to be a $670 million in the six months ending Sept 30 versus $900m in the same period a year earlier.It expects net profit to be $85m-to-$95m, versus $222m in the six months to Sep 30, 2021. The company's shares fell as low as $19.11 in early trading, and were recently down 6.6% at $19...

More Markets

Tower's risk-based revolution
Markets

Tower's risk-based revolution

It's one of the few insurers in Australasia growing. How?

RBNZ plan to cut AT1 capital layer wins cautious lender support
Finance

RBNZ plan to cut AT1 capital layer wins cautious lender support

Proposal to pare AT1 capital from prudential stacks wins cautious support from lenders.

NZ sharemarket starts week down 0.8%
Markets Market Close

NZ sharemarket starts week down 0.8%

The S&P/NZX 50 Index closed at 13,351.92, down 115.34 points or 0.86%.

Graham Skellern 13 Oct 2025
ANZ NZ continues to hold market-leading position: ANZ Group
Finance

ANZ NZ continues to hold market-leading position: ANZ Group

ANZ NZ holds market-leading position, continues re-platforming: ANZ Group 

Staff reporters 13 Oct 2025